Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS Council approves a new Language Policy
2016-03-11

The Council of the University of the Free State (UFS) approved a new Language Policy with an overwhelming majority during its meeting held on the Qwaqwa Campus today (11 March 2016).

In the newly approved policy, the university commits to embed and enable a language-rich environment committed to multilingualism, with particular attention to Afrikaans, Sesotho, isiZulu, and other languages represented on the three campuses situated in Bloemfontein and Qwaqwa.

Based on the core values of inclusivity and multilingualism, the following principles in the newly approved policy were approved by the Council:

  1. English will be the primary medium of instruction at undergraduate and postgraduate level on the three campuses situated in Bloemfontein and Qwaqwa.
  2. Multilingualism will be supported among other activities by an expanded tutorial system especially designed for first-year students.
  3. In particular professional programmes such as teacher education and the training of students in Theology who wish to enter the ministry in traditional Afrikaans speaking churches, where there is clear market need, the parallel medium English-Afrikaans and Sesotho/Zulu continues. This arrangement must not undermine the values of inclusivity and diversity endorse by the UFS.
  4. The primary formal language of the university administration will be English with sufficient flexibility for the eventual practice of multilingualism across the university.
  5. Formal student life interactions would be in English, while multilingualism is encouraged in all social interactions.

“This is a major step forward for the UFS. I commend Council for their constructive and positive manner in which the discussion took place,” says Judge Ian van der Merwe, Chairperson of the UFS Council.

The university furthermore committed in the newly approved policy to:

  1. Ensuring that language is not a barrier to equity of access, opportunity and success in academic programmes or in access to university administration.
  2. Promoting the provision of academic literacy, especially in English, for all undergraduate students.
  3. Ensuring that language is not used or perceived as a tool for social exclusion of staff and/or students on any of its campuses.
  4. Promoting a pragmatic learning and administrative environment committed to and accommodative of linguistic diversity within the regional, national and international environments in which the UFS operates.       
  5. Contributing to the development of Sesotho and isiZulu as higher education language within the context of the needs of the university’s different campuses.
  6. The continuous development of Afrikaans as an academic language.
  7. Recognising and promoting South African Sign Language and Braille.

Today’s approval of a new policy comes after a mandate was given to the university management on 5 June 2015 by Council to conduct a review of the institutional Language Policy through a comprehensive process of consultation with all university stakeholders. A Language Committee was subsequently established by the University Management Committee (UMC) to undertake a comprehensive review of the parallel-medium policy, which was approved by Council on 6 June 2003. The committee also had to make recommendations on the way forward with respect to the university's Language Policy. During its meeting on 4 December 2015, Council adopted guidelines from the report of the Language Committee regarding the development of a new policy for the university.

The newly approved Language Policy will be phased in as from January 2017 according to an Implementation Plan.

Released by:
Lacea Loader (Director: Communication and Brand Management)
Email: news@ufs.ac.za

Related articles:

http://www.ufs.ac.za/templates/news-archive-item?news=6567 (26 November 2015)
http://www.ufs.ac.za/templates/news-archive-item?news=6540 (28 October 2015)
http://www.ufs.ac.za/templates/news-archive-item?news=6521 (20 October 2015)
http://www.ufs.ac.za/templates/news-archive-item?news=6469 (30 August 2015)
http://www.ufs.ac.za/templates/news-archive-item?news=6444 (25 August 2015)

 
Released by:
Lacea Loader (Director: Communication and Brand Management)
Telephone: +27(0)51 401 2584 | +27(0)83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27(0)51 444 6393

 

 


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept